Michael Barlow, DO
Orthopaedic Surgery · Nashville, TNNPI 1649628371
Payments from drug & device makers
What this record shows
This record is dominated by grants: $32,468 of the $42,248 with a category attached, or 76.9%. 11 manufacturers reported payments, led by Arthrex at 55.8% of the total. Reporting peaked in 2021 at $34,044 and has fallen 99.4% since, to $219 in 2025.
Across 65 payments — averaging $649.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$24K
- DJO, LLC$8K
- Medical Device Business Services, Inc.$5K
- Fortis Surgical, LLC$5K
- Smith+Nephew$314
- Alpha Orthopedic Systems$269
- plus $367 from 5 others
What the payments were for
- Grants$32,46877%
- Travel & lodging$8762%
- Food & beverage$1,3743%
- Education$7,53018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 25 | $23,588 |
| DJO, LLC | 4 | $7,500 |
| Medical Device Business Services, Inc. | 5 | $5,357 |
| Fortis Surgical, LLC | 8 | $4,852 |
| Smith+Nephew | 9 | $314 |
| Alpha Orthopedic Systems | 5 | $269 |
| Stryker | 4 | $218 |
| Johnson & Johnson | 1 | $77 |
| Vertex | 2 | $34 |
| Bioventus LLC | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,248 in reported general payments places this provider in the 85th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 158 | $1,917 |
| Diclofenac Sodium | 93 | $860 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 129 | $609 |
| Meloxicam | 138 | $394 |
| Ondansetron Hcl | 51 | $266 |
| Ondansetron OdtOndansetron | 23 | $263 |
| Gabapentin | 23 | $194 |
| Cyclobenzaprine Hcl | 36 | $131 |
| Ibuprofen | 28 | $103 |
| Methylprednisolone | 19 | $79 |
| Cephalexin | 16 | $49 |
| Tramadol Hcl | 21 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nashville
- Jefferson MorrisonNashville$678K
- Gregory PolkowskiNashville$526K
- Matthew WillisNashville$498K
- Michael ChristieNashville$474K
- David DeboerNashville$448K
- Rudolph GlattesNashville$444K
- John MartinNashville$212K
- Nicholas StrasserNashville$184K
- Jeffrey HodrickNashville$173K
- Brian DierckmanNashville$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.